Mr. Thierry Vernier was Vice President Plan & Financial Control, Member of the Global Leadership Team of Sanofi SA since January 2011. He is a graduate of ESC Le HavreCaen, now Ecole de Management de Normandie and holds a Diploma in Accounting and Finance . He began his career as an external auditor for KPMG in 1990, later becoming Deputy Controller of Coflexip Stena Offshore. He joined Sanofi SA in 1996 as Consolidation Director, and became successively Finance and Administration Director for Nordic countries and the United Kingdom. He held various Senior Corporationrationrate Finance functions since 2004, including Vice President, Financing and Treasury before becoming Vice President, Plan & Financial Evaluation in 2009.
Vice President - Plan & Financial Control, Member of the Global Leadership Team
President Since 2011
The company has Return on Asset of 4.95 % which means that on every $100 spent on asset it made $4.95 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.02 % implying that it generated $9.02 on every 100 dollars invested.
The company has 18.82 B in debt with debt to equity (D/E) ratio of 0.25 which may show that the company is not taking advantage of profits from borrowing. Sanofi has Current Ratio of 1.62 which is typical for the industry and considered as normal.
Entity SummarySanofi researches, develops, manufactures, and markets healthcare solutions worldwide. Sanofi [SNY] is traded on New York Stock Exchange in USA. It is located in , Rue La BoParis, and employs 111,974 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| SNY NYSE
Sanofi has less than 15.64 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Sanofi price boundaries
Promote Sanofi and Thierry Vernier